Literature DB >> 24328882

Chemotherapy and immunotherapy of brain tumors: what the epileptologist must know.

Lisa R Rogers1.   

Abstract

I present an overview of therapy for the most common brain tumors encountered in clinical practice if adult patients. Current therapy paradigms and evolving therapies are reviewed. The introduction of non-enzyme-inducing antiepileptic drugs (NEIADs) has simplified the approach to combined medical treatment of epilepsy and brain tumors, but the major interactions between enzyme-inducing antiepileptic drugs (EIAEDs) are included, to serve as guidance in selecting these medications if they are required. Wiley Periodicals, Inc.
© 2013 International League Against Epilepsy.

Entities:  

Keywords:  Bevacizumab; CNS neoplasm; Glioma; O6-methylguanine DNA methyltransferase; Temozolomide

Mesh:

Substances:

Year:  2013        PMID: 24328882     DOI: 10.1111/epi.12453

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  3 in total

1.  Establishment of pancreatic cancer stem cells by flow cytometry and their biological characteristics.

Authors:  Dandan Li; Dongyue Su; Lei Xue; Yang Liu; Wuyan Pang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 2.  A neuropathology-based approach to epilepsy surgery in brain tumors and proposal for a new terminology use for long-term epilepsy-associated brain tumors.

Authors:  Ingmar Blumcke; Eleonora Aronica; Horst Urbach; Andreas Alexopoulos; Jorge A Gonzalez-Martinez
Journal:  Acta Neuropathol       Date:  2014-05-25       Impact factor: 17.088

3.  Patients treatment with neuroglioma by teniposide and semustine and its influence on Twist and E-cadherin expression.

Authors:  Yongbo Zhang; Guoyi Liu; Meiling Lang; Jing Zhang; Jia Geng
Journal:  Saudi Pharm J       Date:  2016-05-05       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.